Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy

Clinical trial NCT02843399 · COMPLETED

Trial details

NCT number: NCT02843399
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus Type 2

Start date: 2016-08-15
Primary completion: 2016-12-15
Enrollment: 15498

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.